Fox Run Management, L.L.C. Acadia Pharmaceuticals Inc Transaction History

Fox Run Management, L.L.C.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $296,815 - $373,962	20,302 New	20,302 $329,000
Q3 2023 Nov 07, 2023	BUY	$20.84 - $33.47 $489,260 - $785,775	23,477 New	23,477 $489,000
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $1.04 Million - $1.33 Million	63,707 New	63,707 $1.2 Million
Q3 2022 Nov 07, 2022	BUY	$14.11 - $18.27 $68,334 - $88,481	4,843 Added 48.06%	14,920 $244,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $182,439 - $381,706	-14,023 Reduced 58.19%	10,077 $142,000
Q1 2022 May 10, 2022	BUY	$20.94 - $27.5 $504,654 - $662,750	24,100 New	24,100 $584,000
Q4 2021 Feb 09, 2022	SELL	$16.79 - $27.09 $201,933 - $325,811	-12,027 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $14,991 - $23,531	-950 Reduced 7.32%	12,027 $200,000
Q2 2021 Aug 05, 2021	BUY	$19.4 - $27.42 $251,753 - $355,829	12,977 New	12,977 $317,000
Q3 2020 Oct 29, 2020	SELL	$36.42 - $57.0 $253,410 - $396,606	-6,958 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$39.26 - $52.73 $273,171 - $366,895	6,958 New	6,958 $334,000
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $448,641 - $636,846	-12,390 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$22.22 - $44.01 $275,305 - $545,283	12,390 New	12,390 $446,000
Q3 2018 Oct 05, 2018	SELL	$13.03 - $21.81 $336,460 - $563,177	-25,822 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$15.07 - $22.34 $389,137 - $576,863	25,822 New	25,822 $394,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.